Gilead Sciences is a corporate/pharmaceutical funder whose philanthropic activity centers on advancing diagnosis, treatment, prevention and equitable access for viral diseases (especially HIV and viral hepatitis), emerging infectious diseases, and related community health needs. They support a mix of clinical research, public health programs, community-based organizations serving marginalized populations (including LGBTQ+ people and people who use drugs), and capacity-building efforts that improve care delivery and linkage to treatment. Gilead gives both domestically and globally and often coordinates grants with programmatic partnerships, product donations, and targeted initiatives in crisis response and health equity.
Combination of programmatic initiative grants and partnerships (including RFP-driven and invitation-only programs), philanthropic foundation grants, in-kind product donations, and awards/support for clinical research; funding ranges from small community grants to multi-year, larger institutional awards and is focused around defined programs and campaigns rather than open unrestricted funding.
Sign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Check Gilead and Gilead Foundation program pages for current initiatives and RFPs, align proposals with their priorities (HIV, HCV, harm reduction, health equity), emphasize measurable outcomes and partnerships with clinical providers, and expect program-specific eligibility or invitation processes rather than unsolicited unrestricted general grants.
Current and upcoming funding from Gilead Sciences, Inc. that your nonprofit may be able to apply for.
Who can apply: LOIs should address one or more listed AmBisome topic areas and be submitted in Gilead OPTICS by June 30, 2026.
Deadline: LOIs received by June 30, 2026
Who can apply: Concepts must address implementation of updated HBV treatment guidelines and shared-decision making; concepts proposing only new HBV testing will not be considered.
Deadline: Rolling until funds are exhausted
Who can apply: Concepts should focus on models of care supporting informed treatment initiation for HCV-positive pregnant patients, including post-treatment follow-up and postpartum outcomes.
Deadline: Rolling until funds are exhausted
Who can apply: Concepts should evaluate reflex or double-reflex HDV testing and linkage-to-care strategies in HBsAg-positive populations and address care cascade gaps.
Deadline: Ongoing evaluation; no fixed deadline stated
Deadline: LOI due July 12, 2026.
Track these deadlines, get reminders, and see how well your nonprofit fits — free with a Kindora account.
Create a free accountDeadlines and eligibility are summarized from public sources and may change — always confirm the details on the funder's official application page before applying.